Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
I am Jess Bruce Assistant Manager in Transparency Market Research (TMR). TMR is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of ...
Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2- early breast cancer (EBC): Results from the ADAPT trial. Rate of medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback